Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia

References

1. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002;288:2015–22.10.1001/jama.288.16.2015Search in Google Scholar

2. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56:111–28.Search in Google Scholar

3. Mudd SH, Levy HL, Kraus JP. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Vale D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 2001:2007–56.Search in Google Scholar

4. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985; 37:1–31.Search in Google Scholar

5. Zylberstein DE, Bengtsson C, Bjorkelund C, Landaas S, Sundh V, Thelle D, et al. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg. Circulation 2004; 109:601–6.10.1161/01.CIR.0000112581.96154.EASearch in Google Scholar

6. Vasan RS, Beiser A, D'Agostino RB, Levy D, Selhub J, Jacques PF, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. J Am Med Assoc 2003; 289:1251–7.10.1001/jama.289.10.1251Search in Google Scholar

7. Riksen NP, Rongen GA, Blom HJ, Russel FG, Boers GH, Smits P. Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia. Cardiovasc Res 2003; 59:271–6.10.1016/S0008-6363(03)00462-0Search in Google Scholar

8. Riksen NP, Rongen GA, Boers GH, Blom HJ, van den Broek PH, Smits P. Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 2005; 25:109–14.10.1161/01.ATV.0000150651.85907.69Search in Google Scholar PubMed

9. Chen YF, Li PL, Zou AP. Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function. Circulation 2002; 106:1275–81.10.1161/01.CIR.0000027586.64231.1BSearch in Google Scholar PubMed

10. Nappo F, De Rosa N, Marfella R, De Lucia D, Ingrosso D, Perna AF, et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. J Am Med Assoc 1999; 281:2113–8.10.1001/jama.281.22.2113Search in Google Scholar PubMed

11. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 1999; 99:1156–60.10.1161/01.CIR.99.9.1156Search in Google Scholar

12. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338:1042–50.10.1056/NEJM199804093381507Search in Google Scholar PubMed

13. Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2003; 23:418–24.10.1161/01.ATV.0000061735.85377.40Search in Google Scholar PubMed

14. Blom HJ, van der Molen EF. Pathobiochemical implications of hyperhomocysteinemia. Fibrinolysis 1994; 8(Suppl 2):86–7.10.1016/0268-9499(94)90257-7Search in Google Scholar

15. Wang H, Yoshizumi M, Lai K, Tsai JC, Perrella MA, Haber E, et al. Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem 1997; 272:25380–5.10.1074/jbc.272.40.25380Search in Google Scholar

16. Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, et al. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res 2001; 88:1203–9.10.1161/hh1101.092180Search in Google Scholar

17. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275:29318–23.10.1074/jbc.M002725200Search in Google Scholar

18. Ueland PM. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol Rev 1982; 34:223–53.Search in Google Scholar

19. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 2001; 74:723–9.10.1093/ajcn/74.6.723Search in Google Scholar

20. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998; 157(Suppl 2):S40–S44.10.1007/PL00014300Search in Google Scholar

21. Blom HJ. Consequences of homocysteine export and oxidation in the vascular system. Semin Thromb Hemost 2000; 26:227–32.10.1055/s-2000-8467Search in Google Scholar

22. van der Molen EF, Hiipakka MJ, Lith-Zanders H, Boers GH, van den Heuvel LP, Monnens LA, et al. Homocysteine metabolism in endothelial cells of a patient homozygous for cystathionine beta-synthase (CS) deficiency. Thromb Haemost 1997; 78:827–33.10.1055/s-0038-1657636Search in Google Scholar

23. Achterberg PW, de Tombe PP, Harmsen E, de Jong JW. Myocardial S-adenosylhomocysteine hydrolase is important for adenosine production during normoxia. Biochim Biophys Acta 1985; 840:393–400.10.1016/0304-4165(85)90220-XSearch in Google Scholar

24. Kloor D, Delabar U, Muhlbauer B, Luippold G, Osswald H. Tissue levels of S-adenosylhomocysteine in the rat kidney: effects of ischemia and homocysteine. Biochem Pharmacol 2002; 63:809–15.10.1016/S0006-2952(01)00892-9Search in Google Scholar

25. Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost 2000; 26:219–25.10.1055/s-2000-8466Search in Google Scholar

26. Deussen A. Metabolic flux rates of adenosine in the heart. Naunyn Schmiedebergs Arch Pharmacol 2000; 362:351–63.10.1007/s002100000318Search in Google Scholar

27. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25:33–9.10.1016/j.it.2003.11.003Search in Google Scholar

28. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53:527–52.Search in Google Scholar

29. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989; 32:73–97.10.1016/0033-0620(89)90015-7Search in Google Scholar

30. Riksen NP, Smits P, Rongen GA. Ischaemic preconditioning: from molecular characterization to clinical application. Part I. Neth J Med 2004; 62:353–63.Search in Google Scholar

31. Tabrizchi R, Bedi S. Pharmacology of adenosine receptors in the vasculature. Pharmacol Ther 2001; 91:133–147.10.1016/S0163-7258(01)00152-8Search in Google Scholar

32. Jackson EK. Adenosine: a physiological brake on renin release. Annu Rev Pharmacol Toxicol 1991; 31:1–35.10.1146/annurev.pa.31.040191.000245Search in Google Scholar

33. Rongen GA, Lenders JW, Lambrou J, Willemsen JJ, Van Belle H, Thien T, et al. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension 1996; 27:933–8.10.1161/01.HYP.27.4.933Search in Google Scholar

34. Smits P, Lenders JW, Willemsen JJ, Thien T. Adenosine attenuates the response to sympathetic stimuli in humans. Hypertension 1991; 18:216–23.10.1161/01.HYP.18.2.216Search in Google Scholar

35. Edlund A, Siden A, Sollevi A. Evidence for an anti-aggregatory effect of adenosine at physiological concentrations and for its role in the action of dipyridamole. Thromb Res 1987; 45:183–90.10.1016/0049-3848(87)90172-1Search in Google Scholar

36. Minamino T, Kitakaze M, Asanuma H, Tomiyama Y, Shiraga M, Sato H, et al. Endogenous adenosine inhibits P-selectin-dependent formation of coronary thrombo-emboli during hypoperfusion in dogs. J Clin Invest 1998; 101:1643–53.10.1172/JCI635Search in Google Scholar PubMed PubMed Central

37. Deguchi H, Takeya H, Urano H, Gabazza EC, Zhou H, Suzuki K. Adenosine regulates tissue factor expression on endothelial cells. Thromb Res 1998; 91:57–64.10.1016/S0049-3848(98)00045-0Search in Google Scholar

38. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 2002; 22:364–73.10.1161/hq0302.105360Search in Google Scholar PubMed

39. Peyot ML, Gadeau AP, Dandre F, Belloc I, Dupuch F, Desgranges C. Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A(2b)-purinoceptor. Circ Res 2000; 86:76–85.10.1161/01.RES.86.1.76Search in Google Scholar

40. Dubey RK, Gillespie DG, Jackson EK. A(2B) adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 2002; 39:530–5.10.1161/hy0202.103075Search in Google Scholar PubMed

41. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992; 85:893–904.10.1161/01.CIR.85.3.893Search in Google Scholar PubMed

42. Schrader J, Schutz W, Bardenheuer H. Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart. Biochem J 1981; 196:65–70.10.1042/bj1960065Search in Google Scholar PubMed PubMed Central

43. Deussen A, Borst M, Schrader J. Formation of S-adenosylhomocysteine in the heart. I: an index of free intracellular adenosine. Circ Res 1988; 63:240–9.10.1161/01.RES.63.1.240Search in Google Scholar

44. Sciotti VM, Van Wylen DG. Attenuation of ischemia-induced extracellular adenosine accumulation by homocysteine. J Cereb Blood Flow Metab 1993; 13:208–13.10.1038/jcbfm.1993.25Search in Google Scholar PubMed

45. Reddington M, Pusch R. Adenosine metabolism in a rat hippocampal slice preparation: incorporation into S-adenosylhomocysteine. J Neurochem 1983; 40:285–90.10.1111/j.1471-4159.1983.tb12684.xSearch in Google Scholar PubMed

46. Henrichs KJ, Matsuoka H, Schaper W. Intracellular trapping of adenosine during myocardial ischemia by L-homocysteine. Basic Res Cardiol 1986; 81:267–75.10.1007/BF01907409Search in Google Scholar PubMed